OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Respiratory and Critical Care Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Constructing Modern Pulmonary Rehabilitation: Another Brick from the Wall	1509
Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis	338
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-Containing Regimens for Drug-Sensitive Tuberculosis: 12-Week Results	301
COVID-19 and Risk of Oxygen-Dependent Chronic Respiratory Failure: A National Cohort Study	278
Targeting Autotaxin and Lysophosphatidic Acid in Pulmonary Fibrosis: Admilparant’s Positive Results Show Continued Promise	273
October 1 Highlight	243
Daily Exposure to Mild Intermittent Hypoxia Reduces Blood Pressure in Male Patients with Obstructive Sleep Apnea and Hypertension	234
Drug Therapy for Obstructive Sleep Apnea: Are We There Yet?	231
Regulating the Regulators: Epigenetic Modulation of Regulatory T Cells in Pulmonary Hypertension	199
Reply to Jankowich: PRISm: What?s in a Name?	195
Determinants of Lung Fissure Completeness	183
Outdoor Air Pollution and Your Health	180
Progressive Pulmonary Fibrosis: Putting the Cart Before the Horse	169
Good’s Syndrome: Thymoma with Acquired Immunodeficiency	163
Systemic Air Embolism and Mediastinal Emphysema after Pneumonia	159
Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease	156
Lipofibroblasts in Structurally Normal, Fibrotic, and Emphysematous Human Lungs	151
Use FEV₁/FVC Z-Score Staging to Minimize Sex and Age Bias in Staging Chronic Obstructive Pulmonary Disease	150
In Case of Invasive Nodule, Break Ground Glass	148
Electrical Impedance Tomography to Evaluate Sigh Effects in Unilateral Lung Injury	140
Endobronchial Clear-Cell Sugar Tumor	139
The 4DPRR Index and Mechanical Power: A Step Ahead or Four Steps Backward?	134
Why Home Noninvasive Ventilation Should Begin in the Hospital, Not at Home	129
No One Left Behind: Access to Prevention and Treatment for All: Message on World Lung Day from M. Patricia Rivera, M.D. President of the American Thoracic Society	128
Crossing Kingdoms: Host–Microbial Endotyping and the Quest to Understand Treatable Traits in Chronic Obstructive Pulmonary Disease	126

Be the Change: Advancing Lung Health and Closing the Global Healthcare Gap	126
Air Pollution and Bronchitis: Childhood Exposure, Lifelong Consequences	122
Mycobacterium tuberculosis: A Pathogen That Can Hold Its Breath a Long Time	122
CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease	121
Reply to Wendel-Garcia et al.: Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support	119
Extracorporeal Membrane Oxygenation Transport for Severe COVID-19: Why We Can and Should!	115
Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions	112
Big Things Have Small Beginnings: Clinical Implications of Early Interstitial Lung Disease	111
COPD Detection: Hurdles and Struggles	110
Stop the Asthma Treatment Elevator, We Need to Get Off!	109
Genetically Identifying the “Thromboembolic” in Chronic Thromboembolic Pulmonary Hypertension	102
Clinical Guidelines: Asking the Right Questions to Guide Fungal Infection Management	102
Alveolar Collapse Is a Threat in Injured Lungs, but What About the Airway Opening Pressure?	99
Does Autoimmune Response Against Surfactant Protein Cause Interstitial Lung Disease?	97
Uncontrollable Hemoptysis owing to Pseudoangiosarcomatous Carcinoma of the Lung	93
Reply to Kasugai et al.: The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19	92
Significant Airway Obstruction by Carbonaceous Fibrin Casts in a Child with Smoke Inhalation Injury	90
Pulmonary Embolus and Hemoptysis Revealing Rare Intralobar Sequestration	90
Race-based Reference Equation for Lung Function Testing in African Americans	89
Enhancing Our Understanding of Breathing Mechanics in Nonintubated Patients with Acute Hypoxemic Respiratory Failure	88
Impaired Lung Function in Extremely Preterm–Born Adults in Their Fourth Decade of Life	87
Managing Your Asthma: Avoiding Irritants	86
Mediastinal Lymph Node Silicotic Nodules and Occupational Exposure to Respirable Crystalline Silica: A Controlled Study in Patients with Lung Cancer	86
Diaphragm Dysfunction as a Contributor to Breathlessness after COVID-19 Infection	84
Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension	84
Extending the Benefits of Pulmonary Rehabilitation to New Groups: Reply to Anidi et al.	84
Reply to Hsiao and Chen: Refining the Concept of Disease Stability in COPD: Bridging Complexity and Clinical Practice	83
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation	83
Histological Chorioamnionitis Increases the Risk of Bronchopulmonary Dysplasia	81
Nasal High Flow to Modulate Dyspnea in Orally Intubated Weanable Patients	81
Impact of Ambient Ultrafine Particles on Cause-Specific Mortality in Three German Cities	81
Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis	78
CD4⁺T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1–Dependent	77
The Many Roles of Cholesterol in Sepsis: A Review	77
Viral Infection, Pulmonary Fibrosis, and Long COVID	77
Oxygen-Saturation Targets and Cognitive and Functional Outcomes in Mechanically Ventilated Adults	77
A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature	74
Interventions Relieving Dyspnea in Intubated Patients Show Responsiveness of the Mechanical Ventilation–Respiratory Distress Observation Scale	73
Pulmonary FABP4 Is an Inverse Biomarker of Pneumonia in Critically Ill Children and Adults	72
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension	72
Evaluation of Droplet Countermeasures by a Particle Visualization System in Simulated Bronchoscopy	71
Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping	71
Risks and Benefits of Ultra–Lung-Protective Invasive Mechanical Ventilation Strategies with a Focus on Extracorporeal Support	70
Anti-acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?	69
May 1 Highlight	68
Plastic Bronchitis in HIV-associated Kaposi Sarcoma	68
Role of Artificial Intelligence in Assisting Pulmonary and Critical Care Clinical Decision-Making	68
Reply to Chen et al.	68
Nurse-to-Nurse Familiarity and Mortality in the Critically Ill: A Multicenter Observational Study	67
A World Health Organization–Derived Framework for E-Cigarette Policy	66

Neuromuscular Blockade Improves Results in Acute Respiratory Distress Syndrome: A Mechanism May Be Prevention of Expiratory Muscle Activity, Which Allows More Lung Expansion	66
Reply to: Combination of Aroxybutynin and Atomoxetine in Obstructive Sleep Apnea: Is the Effect One Plus One Greater Than Two?	66
Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That’s the Question	65
The Role of Basement Membrane Thickening in Airway Physiology and Immunopathology of Severe Asthma	65
Reply to Volpicelli and Bouhemad	65
Seeing through the MIST: A Pathway Toward Optimal Intervention for Pleural Infection	65
It’s Not Just a Smoking-related Disease: Outdoor Pollution May Increase Risk of Chronic Obstructive Pulmonary Disease	64
Is Glycemic Control the Secret to Tuberculosis Control?	64
Endotracheal Xanthoma Disseminatum	64
Cardiopulmonary Health Burden of Wildfire Particulate Exposure Urges Us to Consider Interventions	64
The Unusual Suspect of Carcinoid Tumor: Salivary Gland in Airway Anyone?	64
Reply to Chen et al.: Mild Intermittent Hypoxia: A New Treatment Approach for Patients with Obstructive Sleep Apnea and Hypertension	63
Tuberculosis: First in Flight	62
Breathing Hope into Directed Therapy for Pulmonary Infections	61
Reply to Leisman and Crowley	61
Bilioptysis Caused by Bronchobiliary Fistula	60
Reply to Al-Ward et al.: HIV, Sepsis, and Post-Discharge Mortality in Sub-Saharan Africa	60
Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease	59
The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction	59
Subphenotypes Assigned to Pediatric Acute Respiratory Failure Patients Show Differing Outcomes	59
Positive- and Negative-Pressure Ventilation Characterized by Local and Global Pulmonary Mechanics	59
Volume–OXygenation Index to Predict High-flow Nasal Cannula Failure: How to Capture the Tidal Volume Matters	58
Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized, Controlled Trial (RELIEF)	58
Associations between Inhaled Corticosteroid Use in the First 6 Years of Life and Obesity-related Traits	58
Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants	58
Of Mucus and Microbes: The Sticky Issue of Mucin–Microbiome Interactions in Chronic Obstructive Pulmonary Disease	57
An Evaluation of the Asthma Impact of the June 2023 New York City Wildfire Air Pollution Episode	57
Comparison of Race-Neutral versus Race-Specific Spirometry Equations for Evaluation of Child Asthma	57
Dual αvβ6 and αvβ1 Inhibition Over 12 Weeks Reduces Active Type 1 Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial	57
Lower Immunoglobulin G Levels Increased Exacerbation Risk in COPD: New Insights for Clinical Practice	57
Emergency Tracheal Intubation: A Procedure in Need of Better Evidence	57
Airway Mucus Plugs on Chest Computed Tomography Are Associated with Exacerbations in COPD	56
A Pilot Randomized Controlled Trial of an Intervention to Improve Perception of Lung Function in Older Adults with Asthma	55
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions	55
Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients	55
Beneficial Effects of Noninvasive Ventilation after Extubation in Obese or Overweight Patients: A Post Hoc Analysis of a Randomized Clinical Trial	55
Single-Cell Analysis Reveals Novel Immune Perturbations in Fibrotic Hypersensitivity Pneumonitis	55
Diaphragm Neurostimulation Assisted Ventilation in Critically Ill Patients	54
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis	54
Inappropriate Determinations of Inappropriateness for Lung Cancer Screening	54
The Shorter, the Better: Can We Improve Efficiency of Idiopathic Pulmonary Fibrosis Trials?	54
The Frail Evidence Base for Early Rehabilitation	54
Ferroptosis Inhibition Combats Metabolic Derangements and Improves Cardiac Function in Pulmonary Artery Banded Pigs	53
September 1 Highlight	53
Erratum: Exposome Profiles and Asthma among French Adults	53
Bronchiectasis, the Latest Eosinophilic Airway Disease: What About the Microbiome?	53
Erratum: Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness	52
Does Lung Protective Ventilation Work in Acute Brain Injury?	52
Pulmonary Ionocytes: What Are They Transporting and Which Way?	52
Lessons about Low-Dose Morphine at the Intersection of Sleep and Breathlessness	51
Virtual Peer Support for ICU Survivors Is Feasible and May Improve Outcomes for ICU Survivors: Results from the icuRESOLVE-D (icu Recovery Solutions Codesigned through Survivor Engagement – Digital) P	51
Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?	50
Reply to Yang and Bing: Respiratory Muscle Training and Weaning	50
SARS-CoV2 Endotheliopathy: Insights from Single Cell RNAseq	50
Clinician Prediction of Hyperinflammatory ARDS Subphenotypes: Overestimated but Prognostic	50
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis	50
Erratum: A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease	50
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!	49
Assessment of Preserved Ratio Impaired Spirometry Using Pre- and Post-Bronchodilator Spirometry in a Randomly Sampled Symptomatic Cohort	49
Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain	49
Simple Aspiration versus Drainage for Complete Pneumothorax: A Randomized Noninferiority Trial	48
Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules	48
YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1	48
Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension	48
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose-associated 90-Day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE III)	48
Air Pollutants and Asthma Hospitalization in the Medicaid Population	48
Reply to de Benedictis: Publication Bias: For How Much Longer?	48
New Guideline Diagnosis of Fibrotic Hypersensitivity Pneumonitis in Idiopathic Pulmonary Fibrosis	48
The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study	48
Strategies for Liberation from Mechanical Ventilation	48
High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo–Renin–Angiotensin-System State	48
Reply to Sokolowska and Radzikowska	47
September 1 Highlight	47
Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta?	47
Is Mechanical Power the One Ring to Rule Them All?	47
Place Matters: Residential Racial Segregation and Chronic Obstructive Pulmonary Disease	46
Association of Noninvasive Respiratory Support with Extubation Outcomes in Brain-injured Patients Receiving Mechanical Ventilation: A Secondary Analysis of the ENIO Prospective Observational Study	46
Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations	46
Pulmonary Artery Pseudoaneurysm as a Complication of Transbronchial Lung Cryobiopsy	46
Prospective Cohort Studies of Major Disorders Can Facilitate Phenotyping for Sleep Apnea	46

Reply to Murray and Newsome	45
Julius Comroe Is Right: Positive and Negative Pressure Ventilation Are the Same	45
February 15 Highlight	45
World Pneumonia Day 2024: Fighting Pneumonia and Antimicrobial Resistance	45
Reconstructing Phenotypes in Recurrent Severe Wheeze in Young Children	45
Quantitative and Qualitative Changes in Peripheral Chemoreceptor Activity in Preterm Infants	45
Procalcitonin: A Mediator of Microvascular Dysfunction during Critical Illness	44
Unveiling the Neuron-mediated Group 2 Innate Lymphoid Cell Activation in Human Asthma	44
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial	44
Early Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: The Costs and Benefits of Case Finding	43
Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical	43
Susceptible Young Adults and Development of Chronic Obstructive Pulmonary Disease Later in Life	43
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness	43
Extending Nasal Continuous Positive Airway Pressure for Preterm Infants: New Targets for an Old Device	43
Dynamic Contrast-enhanced MRI Demonstrates Pulmonary Microvascular Abnormalities Months After SARS-CoV-2 Infection	42
Can Breathing Pattern Assessment Predict the Need of Ventilatory Support in Treated Infants with Spinal Muscular Atrophy Type 1?	42
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment	42
A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves Closer	42
How to Understand a Revolution: Guts, Lungs, and Bronchiectasis	41
Acute OSA Impacts Diurnal Alzheimer’s Biomarkers through Nocturnal Hypoxemia and State Transitions	41
Extracorporeal Membrane Oxygenation during Respiratory Pandemics: Past, Present, and Future	41
Exercise Limitation in Pulmonary Hypertension – Physiological Insights into the 6-Minute Walk Test	41
Lung Cancer Screening	41
Challenging the Paradigm of Persistent Air Leak: Are We Prolonging the Problem?	41
Reply to Stewart and Sundar	40
Epoprostenol and Treprostinil: Differential Effects on Regulatory T-Cell Generation in Patients with Pulmonary Arterial Hypertension	40
Reply to Lalonde et al.: Why Would Physiologic Support with Continuous Positive Airway Pressure Not Improve Outcomes in Patients with Atrial Fibrillation with Sleep Apnea?	40
The Digital 1-Minute Walk Test: A New Patient-centered Cardiorespiratory Endpoint	40
Rare Genetic Variants Provide Protection for Obstructive Sleep Apnea	40
In the Public Health Perspective, There Is Not a Rational Approach of E-Cigarette Use	40
Human Infection Challenge with Serotype 3 Pneumococcus	40
Health Equity	40
Contrast-enhanced Magnetic Resonance Imaging Does Not Detect a Progression in Lung Morphological Score in Preschool Children with Cystic Fibrosis	40
Is It Time to Say Goodbye to Sputum?	39
From Single-omics to Clinically Integrated Multi-omics: Towards Bio-Clinical AI	39
FEV₁ Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn	39
Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita	39
Cardiopulmonary Effects of Increased Mixed Venous Saturation during Venovenous Extracorporeal Membrane Oxygenation	39
New Interventions to Prevent Respiratory Syncytial Virus Disease in Infants—Time for Equitable Global Access	39
Another Step Closer to Genomic-informed Therapeutic Dosing for Tuberculosis Drugs	39
Optimism with Caution: Elexacaftor–Tezacaftor–Ivacaftor in Patients with Advanced Pulmonary Disease	39
Timing for Initiating Home Noninvasive Ventilation in Italy: Beyond Clinical Parameters	38
Reply to Sohal: Vascular Pruning in Smokers, Patients with Small Airway Disease and Early COPD	38
Reclassification of Airflow Limitation: A STAR with a GOLD Lining	38
CX3CR1⁺Alveolar Macrophages: A New Player in Lung Eosinophil Homeostasis	38
Overnight Oximetry–derived Pulse Rate Variability Predicts Stroke Risk in Patients with Obstructive Sleep Apnea	38
Selected Bibliography of Recent Research in Sleep (2020–2021)	37
Oral Microbiota and Pediatric Asthma Phenotype: A New Window for Biomarkers?	37
Combustible and Electronic Cigarette Exposures Increase ACE2 Activity and SARS-CoV-2 Spike Binding	37
Can Four-Dimensional Computed Tomography Assess Dynamic Changes in Lung Volumes in Mechanically Ventilated Patients?	37
Silicosis in Western U.S. Metal and Nonmetal Miners, 2002–2023	37
Abnormal Spirometry and Risk of Dementia: A Focus on Preserved Ratio Impaired Spirometry	37
Cystic Fibrosis Reprograms Airway Epithelial IL-33 Release and Licenses IL-33–Dependent Inflammation	37
Beyond the Lung: Viewing Treatment Response through the Liver in Pulmonary Arterial Hypertension	36
Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases	36
Dulling the Double-edged Sword: Expanding the Arsenal of Diaphragm Protection in Early Respiratory Failure	36
Reply to Sankari: Does Heart Rate Play a Role in Cardiovascular Outcome in Patients with Obstructive Sleep Apnea?	36
Delayed Tuberculosis Paradoxical Reaction Associated with Tumor Necrosis Factor Inhibitors	36
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome	36
Single-Cell Analysis Reveals Distinct Immune and Smooth Muscle Cell Populations that Contribute to Chronic Thromboembolic Pulmonary Hypertension	36
Pulmonary Alveolar Microlithiasis in a Patient with Ellis–van Creveld Syndrome	36
Nuclear Factor-κB Keeps Basal Cells Undifferentiated in Congenital Diaphragmatic Hernia	36
Dynamic ¹¹C-PABA PET/CT for Visualizing Pulmonary Mycobacteroides abscessus Infections	36
Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans	36
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	36
Predicting Obstructive Sleep Apnea Based on Computed Tomography Scans Using Deep Learning Models	36
Reply to Bhatt and to Ramakrishnan et al.	35
Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling	35
PCSK6: The Endogenous PAR-1 Agonist Driving Pulmonary Fibrosis?	35
Reply to Yilmaz and Çetin	35
Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry	34
Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?	34
Use of Wearables and Implantable Devices to Monitor Pulmonary Health in the Outpatient Setting	34
Erratum: Perinatal Hypoxia-Inducible Factor Stabilization Preserves Lung Alveolar and Vascular Growth in Experimental Bronchopulmonary Dysplasia	34
Reply to Oppersma et al.	34
“Weighting” the Evidence: How Much Bedaquiline Is Enough?	34
Endobronchial Valve Lung Volume Reduction and Small Airway Function	33
CoronaVac or BNT162b2 Vaccine as a Third Dose	33
Green Pleural Effusion Secondary to Eosinophilic Autofluorescence	33
Intrapulmonary Bronchopulmonary Anastomoses in Severe COVID-19–related Acute Respiratory Failure	33
Role of Community Health Workers in Chronic Obstructive Pulmonary Disease Care in Low- and Middle-Income Countries	33
A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants	33
Driving Pressure in COVID-19 Acute Respiratory Distress Syndrome Is Associated with Respiratory Distress Duration before Intubation	33
Icenticaftor, a Novel Treatment for Chronic Obstructive Pulmonary Disease, Needs Further Verification of Its Effectiveness	33
Impairment of the NKT–STAT1–CXCL9 Axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Caused by Lung Fibrosis	32
December 1 Highlight	32
Are Adults with Chronic Obstructive Pulmonary Disease Vulnerable to Air Pollution and Cardiovascular Risk?	32
Infection by Clonally Related Mycobacterium abscessus Isolates: The Role of Drinking Water	32
Reply to Li et al. and to Bhattacharya et al.	32
NO Casting of NETs in Allergic Asthma	32
Resilience and Stress Are Heterogenic Too: We Should Act Accordingly	32
Vitamin C Is Mandatory for the Tricarboxylic Acid Cycle Production of Antiinflammatory Itaconate	32
Defining Acute Respiratory Distress Syndrome (Again): A Plea for Honesty	32
The Interaction of Acute Kidney Injury with Resuscitation Strategy in Sepsis: A Secondary Analysis of a Multicenter, Phase 3, Randomized Clinical Trial (CLOVERS)	32
Continuous Monitoring for Atrial Fibrillation in Individuals at Increased Risk of Acute Exacerbations of COPD	31